logo

IPOS

Share SHARE

NovoCure Limited has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission to raise up to $300 million in an initial public offering of common shares. The company did not specify the number of shares to be sold and the pricing. The company said it has applied...

Biopharmaceutical company Cortendo has filed a registration statement on Form F-1 with the U.S. with the SEC to raise up to $86.25 million in an initial public offering. The Trevose, Pennsylvania-based company's stock currently trades on the Norwegian OTC market under the symbol CORT. The company,...

CytomX Therapeutics, Inc. said Friday that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not yet been...

MedEquities Realty Trust Inc. announced that it has filed a registration statement on Form S-11 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock. The number of shares to be sold and the price range for the proposed offering have...

Benitec Biopharma Limited (BNTC, BNTCW, BLT.AX), a clinical-stage biotechnology company, announced the pricing of its U.S. initial public offering of 1.50 million American Depositary Shares or ADSs, representing 30 million fully paid ordinary shares of Benitec and warrants to purchase 500,000 ADSs, representing...

Petco Holdings Inc., which sells supplies, food and services for animals, has filed with the U.S. Securities and Exchange Commission to raise up to $100 million in an initial public offering. The company did not specify the number of shares to be sold and the pricing. The company did not mention...

Edge Therapeutics, Inc., a clinical-stage biotechnology company, filed on Friday with the SEC to raise up to $115 million in an initial public offering. The Berkeley Heights, New York-based company, which was founded in 2009, plans to list on the Nasdaq under the symbol EDGE. The company did...

Blank check company Gores Holdings, Inc. has priced its initial public offering of 35 million units at a price of $10.00 per unit. The units are listed on the NASDAQ Capital Market and began trade under the ticker symbol "GRSHU" on August 14. Each unit consists of one share of the company's Class...

Conifer Holdings Inc.(CNFR) announced that it priced its initial public offering of 3.10 million shares of its common stock at a price to the public of $10.50 per share. The shares will begin trading on the Nasdaq Global Market this morning, under the ticker symbol "CNFR." All of the 3.10 million...

Houlihan Lokey Inc., the international investment bank, announced the pricing of its initial public offering of 10.50 million shares of its Class A common stock at a public offering price of $21.00 per share. The shares are expected to begin trading on Thursday, August 13, 2015 on the New York Stock...

Houlihanlokey-120815.jpg Investment banking firm Houlihan Lokey, Inc. is expected to make its market debut on Thursday by selling 13.06 million shares of its Class A common stock in an initial public offering that will raise about $300 million. The completion of the IPO is expected give the company a market valuation of up to $1.57 billion, based on about 65 million shares outstanding following the offering.

globalblood-ipo-110815.jpg Global Blood Therapeutics, a clinical stage company focused on blood-based therapies, is preparing for an initial public offering. The San Francisco-based company is reportedly planning to raise up to $124.2 million in an IPO that would value it at about $500 million.

Aimmune Therapeutics, Inc. announced the pricing of its initial public offering of 10 million shares of its common stock at a public offering price of $16.00 per share, before underwriting discounts and commissions. In addition, Aimmune has granted the underwriters a 30-day option to purchase up to...

Neiman Marcus Group, Inc., the century-old luxury department-store chain, has filed with the U.S. Securities and Exchange Commission to raise up to $100 million in an initial public offering. The company did not specify the number of shares to be sold and the pricing. The company did not mention...

Zynerba Pharmaceuticals, Inc. said Tuesday that it has priced its initial public offering of 3 million shares at $14.00 per share, which is the mid-point of the previously estimated price range of $13.00 and $15.00 per share. Zynerba has also granted the underwriters an option to purchase up to 450,000...

Follow RTT